(Q45901439)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21088044%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

title

The efficacy of natalizumab in patients with multiple sclerosis according to level of disability: results of an observational study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21088044%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

0 references

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21088044%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

Oscar Fernández

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21088044%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Marcos Papais Alvarenga

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21088044%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Miguel Guerrero

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21088044%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Antonio León

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21088044%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Ana Alonso

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21088044%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Jose Carlos López-Madrona

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21088044%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Begoña Oliver

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21088044%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Enrique de Ramón

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21088044%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Gloria Luque

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21088044%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Victoria Fernández

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21088044%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

publication date

18 November 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21088044%20AND%20SRC:MED&resulttype=core&format=json

Multiple Sclerosis Journal

16 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21088044%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21088044%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21088044%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

192-197

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21088044%20AND%20SRC:MED&resulttype=core&format=json

The epidemiology of multiple sclerosis in Europe.

16 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458510385507

Defining the clinical course of multiple sclerosis: Results of an international survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510385507

Natural history of multiple sclerosis: a unifying concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510385507

Natalizumab plus interferon beta-1a for relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510385507

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510385507

Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510385507

Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510385507

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510385507

Natalizumab reduces clinical and MRI activity in multiple sclerosis patients with high disease activity: results from a multicenter study in Switzerland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510385507

Efficacy of natalizumab in multiple sclerosis patients with high disease activity: a Danish nationwide study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510385507

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510385507

A controlled trial of natalizumab for relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510385507

Natalizumab in the treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510385507

The incidence and significance of anti-natalizumab antibodies: results from AFFIRM and SENTINEL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510385507

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510385507

21 January 2018

Identifiers

DOI

10.1177/1352458510385507

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21088044%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference